Volume 4 Issue 4 - International Biopharmaceutical Industry

Current Edition

Volume 4 Issue 4

Maximising mAbs Purification Efficiency: Focus Areas for Reducing Bottlenecks in Downstream Processing

Finding ways to remove bottlenecks and improve yields in downstream processing for monoclonal antibodies (mAbs) continues to be a key focus area for biopharma manufac...

9 December 2021 Volume 4 Issue 4 Bottlenecks | Downstream Processing

Continue Reading →

Volume 4 Issue 4

Bringing Novel Therapies to Market: 5 Strategies for Success

Advanced therapy medicinal products (ATMPs) were making headlines long before SARS-CoV-2, the virus that causes COVID-19, emerged onto the scene. The successful devel...

9 December 2021 Volume 4 Issue 4 Advanced therapy medicinal products | ATMPs

Continue Reading →

Volume 4 Issue 4

Understanding the Role of Regulatory T Cells in Breast Cancer Metastasis

Breast cancer is the most common cancer amongst women accounting for 24 percent of new cancer cases worldwide and 15 percent of cancer deaths in 2018. While survival ...

9 December 2021 Volume 4 Issue 4 breast cancer | cancer

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Current Edition

Upcoming Events

Advertisement

Maximising mAbs Purification Efficiency: Focus Areas for Reducing Bottlenecks in Downstream Processing

Bringing Novel Therapies to Market: 5 Strategies for Success

Understanding the Role of Regulatory T Cells in Breast Cancer Metastasis

International Biopharmaceutical Industry